Introduction
Ischemic stroke resulting from abrupt interruption of cerebral blood flow remains one of the most devastating neurological diseases with high incidence and mortality [1]. Despite considerable progress including thrombolytic cerebravascular recanalization in the first hours after stroke onset and secondary stroke prevention therapies, there still exist few neuroprotective therapies that effectively reduce brain damage and improve neurological recovery once ischemic stroke has occurred